I was a timid, but curious child who wanted everything I did to be perfect. I aspired to become an engineer like my father and attended school 1,400 miles away and was homesick. To be closer to home, I applied and was accepted to a medical school in my hometown. I took the opportunity seriously and wanted to be a role model to others in my family.
Why I Treat Children
Growing up in India, I was moved by the severity of malnutrition and poverty of children in India. I thought by being a pediatrician, I could serve as an advocate for these children and help change the cycle by giving families resources and avenues to help them raise healthier children.
What I'm Passionate About
As a clinician, I feel completely obligated to give my patients the best treatment possible, to use strong clinical judgment. This is what moves me. At times, it’s difficult. Even though we’ve made great progress and we help many kids, there are some we can’t help. I see a challenge every time there’s a failure, and that inspires me, too.
How I Try to Make A Difference
I was brought up to believe in giving back to the community. It’s what keeps me going and how I practice medicine.
Education & Training
Fellowship
Clinical Pharmacology
- University of Chicago Hospitals,
2003
Pediatric Hematology/Oncology
- University of Chicago Hospitals,
2002
Pediatric Hematology/Oncology
- University of Chicago Hospitals,
1996
Internship
Rotating - Kilpauk Medical College, Madras, India, 1989
Residency
Pediatrics
- University of Chicago Hospitals,
1995
Pediatric Hematology/Oncology
- Apollo Hospitals - India,
1993
Medical/Dental School
MD
- Madras Medical College,
1989
Board Certifications
American Board of Pediatrics/General Pediatrics
American Board of Pediatrics/Hematology-Oncology
Awards & Recognition
2014
Best Doctors in America
2013
Best Doctors in America
2012
America's Top Oncologists
2011
Best Doctors in America
2010
Best Doctors in America
2009
Best Doctors in America
Insurance Accepted
Accountable Health Plans PPO
Aetna Better Health FL Medicaid and Healthy Kids
Aetna HMO/POS/PPO/EPO
AmeriHealth Caritas Florida (FKA Prestige Health Choice)
AvMed
Blue Cross Blue Shield Florida Blue Select
Blue Cross and Blue Shield HMO
Blue Cross and Blue Shield Non HMO
Cigna & Great West HMO/POS Open Access
Cigna & Great West PPO/EPO
Community Care Plan Medicaid
Employers Health Network PPO
Evolutions Healthcare
First Health Aetna PPO/EPO
Florida Medicaid
Florida Medicare
HUMANA HEALTHY HORIZONS (FKA HUMANA MEDICAID)
Health First Health Plans
Humana HMO/POS
Humana PPO/EPO
Molina Healthcare Medicaid
Multiplan PPO
Olympus Managed Healthcare PPO ORL
Prime Health Services PPO Specialty Florida
Seminole Tribe of Florida
Simply Healthcare Healthy Kids
Simply Healthcare Medicaid HMO
Star Healthcare Network
Sunshine SMI/CMS 19 & 21
Sunshine State Health Plan Medicaid
Three Rivers Provider Network
Tricare/Humana Military Health Services
United Healthcare Commercial Products
United Healthcare Community Plan Medicaid HMO
Volusia Health Network PPO/EPO
Medical Interests
Cancer clinical trials
Clinical drug development
Hong, D. S., DuBois, S. G., Kummar, S., Farago, A. F., Albert, C. M., Rohrberg, K. S., & Drilon, A. (2020). Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials. The Lancet Oncology, 21(4), 531-540. doi:10.1016/S1470-2045(19)30856-3 View Full Publication
Janz, T. A., Nagasubramanian, R., & Wei, J. L. (2019a). A Survival Analysis of Pediatric Tonsillar Malignancies and Review of a Rare Case. International Journal of Pediatric Otorhinolaryngology, 118, 160-164. doi:10.1016/j.ijporl.2018.12.033 View Full Publication
Janz, T. A., Nagasubramanian, R., & Wei, J. L. (2019b). Pediatric head and neck fibrosarcomas: A demographical, treatment, and survival analysis and review of a rare case. International Journal of Pediatric Otorhinolaryngology, 116, 92-96. doi:10.1016/j.ijporl.2018.09.031 View Full Publication
DuBois, S. G., Laetsch, T. W., Federman, N., Turpin, B. K., Albert, C. M., Nagasubramanian, R., & Pappo, A. S. (2018). The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas. Cancer, 124(21), 4241-4247. doi:10.1002/cncr.31701 View Full Publication
Laetsch, T. W., DuBois, S. G., Mascarenhas, L., Turpin, B., Federman, N., Albert, C. M., & Hawkins, D. S. (2018). Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study. The Lancet Oncology, 19(5), 705-714. doi:10.1016/S1470-2045(18)30119-0 View Full Publication
Drilon, A., Laetsch, T. W., Kummar, S., Dubois, S. G., Lassen, U. N., Demetri, G. D., & Hyman, D. M. (2018). Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children. New England Journal of Medicine, 378(8), 731-739. doi:10.1056/NEJMoa1714448 View Full Publication
Laetsch, T. W., Nagasubramanian, R., & Casanova, M. (2018). Targeting NTRK fusions for the treatment of congenital mesoblastic nephroma. Pediatric Blood and Cancer, 65(1). doi:10.1002/pbc.26593 View Full Publication
Drilon, A., Nagasubramanian, R., Blake, J. F., Ku, N., Tuch, B. B., Ebata, K., & Hyman, D. M. (2017). A next-generation TRK kinase inhibitor overcomes acquired resistance to prior trk kinase inhibition in patients with TRK fusion-positive solid tumors. Cancer Discovery, 7(9), 963-972. doi:10.1158/2159-8290.CD-17-0507 View Full Publication
Nagasubramanian, R., Wei, J., Gordon, P., Rastatter, J. C., Cox, M. C., & Pappo, A. (2016). Infantile Fibrosarcoma With NTRK3-ETV6 Fusion Successfully Treated With the Tropomyosin-Related Kinase Inhibitor LOXO-101. Pediatric Blood and Cancer, 63(8), 1468-1470. doi:10.1002/pbc.26026 View Full Publication
English
Tamil
Choose a Region
Nemours has a number of service regions. Selecting your region will help us show you the right contact information and the most relevant content for you.